JP2022526978A5 - - Google Patents
Info
- Publication number
- JP2022526978A5 JP2022526978A5 JP2021559092A JP2021559092A JP2022526978A5 JP 2022526978 A5 JP2022526978 A5 JP 2022526978A5 JP 2021559092 A JP2021559092 A JP 2021559092A JP 2021559092 A JP2021559092 A JP 2021559092A JP 2022526978 A5 JP2022526978 A5 JP 2022526978A5
- Authority
- JP
- Japan
- Prior art keywords
- gram
- antibiotic
- polypeptide
- negative
- combination preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962830207P | 2019-04-05 | 2019-04-05 | |
| US62/830,207 | 2019-04-05 | ||
| PCT/US2020/026681 WO2020206327A1 (en) | 2019-04-05 | 2020-04-03 | Lysins and derivatives thereof with bactericidal activity against pseudomonas aeruginosa, in the presence of human serum |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022526978A JP2022526978A (ja) | 2022-05-27 |
| JP2022526978A5 true JP2022526978A5 (https=) | 2023-03-27 |
Family
ID=72667504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559092A Pending JP2022526978A (ja) | 2019-04-05 | 2020-04-03 | ヒト血清の存在下でシュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220160843A1 (https=) |
| EP (1) | EP3946609A4 (https=) |
| JP (1) | JP2022526978A (https=) |
| KR (1) | KR20210148320A (https=) |
| CN (1) | CN114040773A (https=) |
| AU (1) | AU2020256258A1 (https=) |
| BR (1) | BR112021019430A2 (https=) |
| CA (1) | CA3136126A1 (https=) |
| IL (1) | IL286941A (https=) |
| MX (1) | MX2021012166A (https=) |
| WO (1) | WO2020206327A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU24750B1 (es) * | 2020-11-19 | 2025-06-11 | Centro De Investig Y Desarrollo De Medicamentos Cidem | Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes |
| CN116200418A (zh) * | 2021-12-01 | 2023-06-02 | 华南农业大学 | 一种筛选铜绿假单胞菌LasR基因调控网络未知基因突变体的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5701777B2 (ja) * | 2009-02-06 | 2015-04-15 | テクノファージ, インベスティガサン エ デセンボルビメント エム ビオテクノロジア,エスエー | 抗菌性ファージ、ファージペプチド、及びそれらの使用方法 |
| CA2833409A1 (en) * | 2011-04-21 | 2012-10-26 | The Rockefeller University | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria |
| AU2015279705B2 (en) * | 2014-06-26 | 2021-04-01 | The Rockefeller University | Acinetobacter lysins |
| AU2016324307B2 (en) * | 2015-09-17 | 2021-10-21 | Contrafect Corporation | Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby |
| BR112020011433A2 (pt) * | 2017-12-12 | 2020-12-01 | Contrafect Corporation | identificação de lisinas e seus derivados com atividade bacteriana contra pseudomonas aeruginosa |
| CN108103050A (zh) * | 2018-02-11 | 2018-06-01 | 中国医药集团总公司四川抗菌素工业研究所 | 一种铜绿假单胞菌噬菌体裂解酶、其编码基因、重组表达载体及其制备方法和应用 |
| CN112368376A (zh) * | 2018-03-29 | 2021-02-12 | 康特拉费克特公司 | 溶素-抗微生物肽(amp)多肽构建体、溶素、其分离的编码多核苷酸及其用途 |
| WO2020046747A1 (en) * | 2018-08-23 | 2020-03-05 | Contrafect Corporation | Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof |
-
2020
- 2020-04-03 EP EP20785056.1A patent/EP3946609A4/en not_active Withdrawn
- 2020-04-03 AU AU2020256258A patent/AU2020256258A1/en not_active Abandoned
- 2020-04-03 JP JP2021559092A patent/JP2022526978A/ja active Pending
- 2020-04-03 MX MX2021012166A patent/MX2021012166A/es unknown
- 2020-04-03 KR KR1020217036171A patent/KR20210148320A/ko not_active Ceased
- 2020-04-03 CA CA3136126A patent/CA3136126A1/en active Pending
- 2020-04-03 WO PCT/US2020/026681 patent/WO2020206327A1/en not_active Ceased
- 2020-04-03 BR BR112021019430A patent/BR112021019430A2/pt not_active IP Right Cessation
- 2020-04-03 CN CN202080041523.4A patent/CN114040773A/zh active Pending
- 2020-04-03 US US17/601,244 patent/US20220160843A1/en not_active Abandoned
-
2021
- 2021-10-04 IL IL286941A patent/IL286941A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024010053A5 (https=) | ||
| JP2021519083A5 (https=) | ||
| JP2021506769A5 (https=) | ||
| IL277119B1 (en) | Antimicrobial lysine-peptide polypeptide templates, lysines, isolated polynucleotides encoding them and uses thereof | |
| US20250064902A1 (en) | Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby | |
| JP2024010053A (ja) | シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定 | |
| Li et al. | Synergism between host defence peptides and antibiotics against bacterial infections | |
| JP2021533728A5 (https=) | ||
| US20240148840A1 (en) | Chimeric endolysin polypeptide | |
| JP2021519311A5 (https=) | ||
| JP2022526978A5 (https=) | ||
| RU2020128276A (ru) | МОДИФИЦИРОВАННЫЕ ЛИЗИНЫ PlySs2 И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ | |
| JP2023502940A5 (https=) | ||
| CA3136126A1 (en) | Lysins and derivatives thereof with bactericidal activity against pseudomonas aeruginosa, in the presence of human serum | |
| RU2020131450A (ru) | Происходящие из бактериофагов противомикробные полипептиды и их применение против грамотрицательных бактерий | |
| US12606640B2 (en) | Recombinant antimicrobial multidomain polypeptide, methods of producing and uses thereof | |
| RU2021128336A (ru) | Лизины и их производные с бактерицидной активностью против pseudomonas aeruginosa в присутствии сыворотки крови человека | |
| US12091691B2 (en) | Chimeric endolysin polypeptide | |
| RU2021137156A (ru) | Происходящие из бактериофагов противомикробные полипептиды и их применение против грамотрицательных и кислотоустойчивых бактерий | |
| HK40086790A (en) | Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby |